Unlabelled: This study evaluated the Pico-Count (Bioscan, Inc., Washington, DC) flow-through radioactivity detector, designed for use in PET studies of cerebral blood flow.
Methods: The Pico-Count detects the two 511-keV positron annihilation photons with two bismuth germanate detectors operating in coincidence. The detectors, photomultipliers and preamps are housed within a 12 cm x 9 cm x 22 cm box, which includes 16 mm of lead shielding, to allow placement of the detector within 15 cm of the sampling site. The counting electronics are housed in a remote box, which is connected to a laptop computer for process control. The dwell time per sample and the number of samples to collect are entered through the computer and can vary throughout the study. Approximately 22 cm of arterial tubing (which contains 0.11 ml of blood) is looped between the detectors. Typically, blood is withdrawn with a syringe pump at a rate of 2.75 ml/min, which corresponds to a flow rate in the tubing of 9.2 cm/sec. Dispersion within the arterial catheter is measured by observing the response to an input step function and is well-modeled as a monoexponential.
Results: The sensitivity is 270 Hz/(microCi/ml), which corresponds to detecting 6.9% of the positron decays occurring within the detector. The peak counting rate after a 12-mCi injection is approximately 2100 Hz, with the background being less than 0.2%. The dispersion time constant is 1.3 sec, and the delay between radioactivity present at the catheter tip and that measured by the detector is 4.1 sec. The cutoff in the power spectral density of typical human arterial blood time radioactivity curves is far less than the corresponding cutoff for the dispersion function.
Conclusion: The Pico-Count is an excellent detector for continuously monitoring positron radioactivity in blood. Depending on the application, dispersion correction for the detection apparatus may not be needed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Association between skin sympathetic nerve activity and electrocardiogram alterations after subarachnoid hemorrhage.
Physiol Rep
January 2025
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.
While autonomic dysregulation and repolarization abnormalities are observed in subarachnoid hemorrhage (SAH), their relationship remains unclear. We aimed to measure skin sympathetic nerve activity (SKNA), a novel method to estimate stellate ganglion nerve activity, and investigate its association with electrocardiogram (ECG) alterations after SAH. We recorded a total of 179 SKNA data from SAH patients at three distinct phases and compared them with 20 data from controls.
View Article and Find Full Text PDFIn vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats.
Fluids Barriers CNS
January 2025
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.
Background: Iduronate-2-sulfatase (IDS) deficiency (MPS II; Hunter syndrome) is a disorder that exhibits peripheral and CNS pathology. The blood brain barrier (BBB) prevents systemic enzyme replacement therapy (ERT) from alleviating CNS pathology. We aimed to enable brain delivery of systemic ERT by using molecular BBB-Trojans targeting endothelial transcytosis receptors.
View Article and Find Full Text PDFEarly systemic insults following severe sepsis-associated encephalopathy of critically ill patients: association with mortality and awakening-an analysis of the OUTCOMEREA database.
J Intensive Care
January 2025
Medical and Infectious Diseases, ICU, Hospital Bichat-Claude Bernard, Université Paris Cité, AP-HP, Paris, France.
Background: Sepsis-associated encephalopathy (SAE) may be worsened by early systemic insults. We aimed to investigate the association of early systemic insults with outcomes of critically ill patients with severe SAE.
Methods: We performed a retrospective analysis using data from the French OUTCOMEREA prospective multicenter database.
Correction to: Roles of Rufy3 in experimental subarachnoid hemorrhage-induced early brain injury via accelerating neuronal axon repair and synaptic plasticity.
Mol Brain
January 2025
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, Jiangsu, 215006, China.
The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity.
J Neuroinflammation
January 2025
Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA.
The thrombolytic protease tissue plasminogen activator (tPA) is expressed in the CNS, where it regulates diverse functions including neuronal plasticity, neuroinflammation, and blood-brain-barrier integrity. However, its role in different brain regions such as the substantia nigra (SN) is largely unexplored. In this study, we characterize tPA expression, activity, and localization in the SN using a combination of retrograde tracing and β-galactosidase tPA reporter mice.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!